Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| DAR | 8-K | bullish | 6/10 | Darling Ingredients issued a pre-earnings statement providing FY2026 Combined Adjusted EBITDA guidance of $2.2-$2.3 bill | Oct 22, 2026 |
| DGX | 8-K | bullish | 7/10 | Quest Diagnostics reported Q3 2026 revenue of $3.097B (+10.0% YoY) and adjusted diluted EPS of $3.00, beating consensus | Oct 22, 2026 |
| BSTT | 8-K | neutral | 4/10 | BREIT reported preliminary estimated same property NOI for Q3 2026 YTD increased approximately 3% YoY, consistent with t | Oct 22, 2026 |
| BFH | 8-K | bullish | 6/10 | Bread Financial reported Q3 2026 adjusted EPS of $3.84, beating consensus of $3.23 by 18.8%, on revenue of $1.017B vs $1 | Oct 22, 2026 |
| LNN | 8-K | neutral | 5/10 | Lindsay Corp reported Q4 FY2026 revenue of $161.6M (+5% YoY) and diluted EPS of $1.10 (+11% YoY), beating consensus esti | Oct 22, 2026 |
| CURB | 8-K | neutral | 5/10 | Curbline Properties reported Q3 2026 Operating FFO of $0.32 per diluted share, in line with consensus of $0.32, and tota | Oct 22, 2026 |
| SNA | 8-K | bearish | 6/10 | Snap-on reported Q3 2026 net sales of $1,183.7M (-0.6% YoY) and diluted EPS of $4.64, a 10.4% miss vs consensus of $5.18 | Oct 22, 2026 |
| AMAL | 8-K | bullish | 6/10 | Amalgamated Financial Corp. reported record Q3 2026 net income of $36.4M ($1.20 GAAP diluted EPS; $1.14 core diluted EPS | Oct 22, 2026 |
| VREX | 8-K | neutral | 4/10 | Varex Imaging filed an 8-K providing supplemental disclosures to its definitive proxy statement for the pending merger w | Oct 22, 2026 |
| LAZ | 8-K | mixed | 5/10 | Lazard reported Q3 2026 adjusted EPS of $0.36, a 36% YoY decline and a 16% miss vs the $0.43 consensus, while adjusted n | Oct 22, 2026 |
| IIIN | 8-K | bearish | 6/10 | Insteel Industries reported Q4 fiscal 2026 EPS of $0.40, missing the $0.49 consensus, and revenue of $209.3M, above the | Oct 22, 2026 |
| LMT | 8-K | mixed | 6/10 | Lockheed Martin reported Q3 2026 EPS of $7.97, missing consensus estimates of $8.56 by 6.9%, while revenue of $20.7B als | Oct 22, 2026 |
| HBAN | 8-K | bearish | 5/10 | Huntington Bancshares reported Q3 2026 GAAP diluted EPS of $0.33, flat QoQ but down from $0.41 a year ago. Adjusted EPS | Oct 22, 2026 |
| GLND | 8-K | neutral | 2/10 | Board member Roderick McIllree resigned effective immediately on October 20, 2026, with no disagreement cited. The filin | Oct 22, 2026 |
| THRM | 8-K | bearish | 6/10 | Gentherm reported Q3 2026 revenue of $405.1M (+4.7% YoY), slightly above consensus of $402.7M, but GAAP EPS of -$0.08 an | Oct 22, 2026 |
| CGTX | 8-K | bullish | 7/10 | Cognition Therapeutics announced FDA alignment on key elements of a pivotal Phase 3 trial of zervimesine (CT1812) in dem | Oct 22, 2026 |
| ALLE | 8-K | bullish | 7/10 | Allegion reported Q3 2026 results with GAAP EPS of $2.59 (up 18.8% YoY) and adjusted EPS of $2.60 (up 13.0% YoY), beatin | Oct 22, 2026 |
| TTMI | 8-K | bullish | 7/10 | TTM Technologies reported Q3 2026 net sales of $1.2 billion, up 60% YoY, and non-GAAP EPS of $1.46, both all-time quarte | Oct 22, 2026 |
| HON | 8-K | bullish | 7/10 | Honeywell Technologies (HON) reported Q3 2026 adjusted EPS of $2.27, a 34% YoY increase, on sales of $5.0B (+7% organic) | Oct 22, 2026 |
| AITX | 8-K | neutral | 3/10 | AITX subsidiary RAD secured orders for 12 devices across three product lines (RIO Mini, ROSA, TOM) from existing custome | Oct 22, 2026 |
| CVBF | 8-K | bullish | 6/10 | CVB Financial Corp. reported Q3 2026 net earnings of $78.1 million ($0.44 diluted EPS), a sharp sequential improvement f | Oct 22, 2026 |
| FUL | 8-K | mixed | 6/10 | H.B. Fuller completed a $850M private offering of 7.625% senior unsecured notes due 2034, using proceeds to replace a $9 | Oct 21, 2026 |
| SUPN | 8-K | bullish | 6/10 | Supernus announced the FDA recognized seven years of orphan-drug exclusivity for ONAPGO (apomorphine HCl) for advanced P | Oct 21, 2026 |
| PCG | 8-K | neutral | 5/10 | PG&E reported Q3 2026 GAAP EPS of $0.34 (down from $0.37 YoY) and non-GAAP core EPS of $0.41 (down from $0.50 YoY), a 4. | Oct 21, 2026 |
| DTSQ | 8-K | neutral | 3/10 | DT Cloud Star Acquisition Corp's sponsor deposited $28,558 into the trust account to extend the deadline for completing | Oct 21, 2026 |
| TRUG | 8-K | mixed | 5/10 | TruGolf Holdings reports it has regained compliance with Nasdaq's minimum stockholders' equity requirement ($2.5M) follo | Oct 21, 2026 |
| REBN | 8-K | neutral | 5/10 | Reborn Coffee entered into a Master Product Supply Agreement with Visvita Corporation to supply aloe vera beverages and | Oct 21, 2026 |
| ELOX | 8-K | neutral | 4/10 | Eloxx Pharmaceuticals appointed Geno J. Germano to its board (expanding from five to six directors) and announced the fi | Oct 21, 2026 |
| TCBK | 8-K | bullish | 6/10 | TriCo Bancshares reported Q3 2026 net income of $38.0M ($1.18 diluted EPS), a 11.1% sequential increase and a 13.5% YoY | Oct 21, 2026 |
| NWSA | 8-K | neutral | 3/10 | News Corp filed an 8-K to disclose its daily ASX buy-back notification for the 2025 Repurchase Program. As of October 21 | Oct 21, 2026 |